Key Highlights
•
A study found that a specific dose of the COVID-19 antiviral nirmatrelvir/ritonavir is safe and effective for patients with severe kidney problems, including those on dialysis. This provides a crucial treatment option for a high-risk group that was previously difficult to treat.
Source →
•
Researchers discovered that removing a key brain receptor (NMDA) in mice causes initial problems with brain cell communication, but the brain can partially adapt over time. This helps us understand how the brain responds to injury and could inform treatments for neurological disorders.
Source →
•
A new oral form of the chemotherapy drug paclitaxel was shown to be as effective as the standard intravenous version for treating a type of advanced breast cancer. This could allow patients to receive effective cancer treatment at home, avoiding lengthy clinic visits and IV complications.
Source →
•
Adding chemotherapy to a targeted drug significantly improved outcomes for lung cancer patients who have specific genetic mutations that usually make treatment less effective. This offers a new, more effective strategy for a group of patients with limited treatment options.
Source →
•
A therapy that helps patients gradually face their fears was successfully delivered by community mental health teams to people with severe mental illness, reducing their anxiety and improving quality of life. This shows that effective psychological treatment can be integrated into real-world community care settings.
Source →
Stay curious. Stay informed — with
Science Briefing.
Always double check the original article for accuracy.
